Elevated Serum Tau and UCHL-1 Concentrations Within 12 Months of Injury Predict Neurobehavioral Functioning 2 or More Years Following Traumatic Brain Injury: A Longitudinal Study.
Journal
The Journal of head trauma rehabilitation
ISSN: 1550-509X
Titre abrégé: J Head Trauma Rehabil
Pays: United States
ID NLM: 8702552
Informations de publication
Date de publication:
19 Jun 2023
19 Jun 2023
Historique:
medline:
19
6
2023
pubmed:
19
6
2023
entrez:
19
6
2023
Statut:
aheadofprint
Résumé
Blood-based biomarkers have received considerable attention for their diagnostic and prognostic value in the acute and postacute period following traumatic brain injury (TBI). The purpose of this study was to examine whether blood-based biomarker concentrations within the first 12 months of TBI can predict neurobehavioral outcome in the chronic phase of the recovery trajectory. Inpatient and outpatient wards from 3 military medical treatment facilities. A total of 161 service members and veterans classified into 3 groups: (a) uncomplicated mild TBI (MTBI; n = 37), (b) complicated mild, moderate, severe, penetrating TBI combined (STBI; n = 46), and (c) controls (CTRL; n = 78). Prospective longitudinal. Participants completed 6 scales from the Traumatic Brain Injury Quality of Life (ie, Anger, Anxiety, Depression, Fatigue, Headaches, and Cognitive Concerns) within 12 months (baseline) and at 2 or more years (follow-up) post-injury. Serum concentrations of tau, neurofilament light, glial fibrillary acidic protein, and UCHL-1 at baseline were measured using SIMOA. Baseline tau was associated with worse anger, anxiety, and depression in the STBI group at follow-up (R2 = 0.101-0.127), and worse anxiety in the MTBI group (R2 = 0.210). Baseline ubiquitin carboxyl-terminal hydrolase L1 (UCHL-1) was associated with worse anxiety and depression at follow-up in both the MTBI and STBI groups (R2Δ = 0.143-0.207), and worse cognitive concerns in the MTBI group (R2Δ = 0.223). A blood-based panel including these biomarkers could be a useful tool for identifying individuals at risk of poor outcome following TBI.
Identifiants
pubmed: 37335195
doi: 10.1097/HTR.0000000000000877
pii: 00001199-990000000-00091
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Informations de copyright
Copyright © 2023 Wolters Kluwer Health, Inc. All rights reserved.
Déclaration de conflit d'intérêts
The authors declare no conflicts of interest.
Références
Shemilt M, Boutin A, Lauzier F, et al. Prognostic value of glial fibrillary acidic protein in patients with moderate and severe traumatic brain injury: a systematic review and meta-analysis. Crit Care Med. 2019;47(6):e522–e529. doi:10.1097/CCM.0000000000003728
Gan ZS, Stein SC, Swanson R, et al. Blood biomarkers for traumatic brain injury: a quantitative assessment of diagnostic and prognostic accuracy. Front Neurol. 2019;10:446. doi:10.3389/fneur.2019.00446
Shahim P, Zetterberg H. Neurochemical markers of traumatic brain injury: relevance to acute diagnostics, disease monitoring, and neuropsychiatric outcome prediction. Biol Psychiatry. 2022;91(5):405–412. doi:10.1016/j.biopsych.2021.10.010
Hier DB, Obafemi-Ajayi T, Thimgan MS, et al. Blood biomarkers for mild traumatic brain injury: a selective review of unresolved issues. Biomark Res. 2021;9(1):70. doi:10.1186/s40364-021-00325-5
Wang KK, Yang Z, Zhu T, et al. An update on diagnostic and prognostic biomarkers for traumatic brain injury. Expert Rev Mol Diagn. 2018;18(2):165–180. doi:10.1080/14737159.2018.1428089
Lippa SM, Werner JK, Miller MC, Gill JM, Diaz-Arrastia R, Kenney K. Recent advances in blood-based biomarkers of remote combat-related traumatic brain injury. Curr Neurol Neurosci Rep. 2020;20(12):54. doi:10.1007/s11910-020-01076-w
Olivera A, Lejbman N, Jeromin A, et al. Peripheral total tau in military personnel who sustain traumatic brain injuries during deployment. JAMA Neurol. 2015;72(10):1109–1116. doi:10.1001/jamaneurol.2015.1383
Shahim P, Zetterberg H, Tegner Y, Blennow K. Serum neurofilament light as a biomarker for mild traumatic brain injury in contact sports. Neurology. 2017;88(19):1788–1794. doi:10.1212/WNL.0000000000003912
Pattinson CL, Shahim P, Taylor P, et al. Elevated tau in military personnel relates to chronic symptoms following traumatic brain injury. J Head Trauma Rehabil. 2020;35(1):66–73. doi:10.1097/HTR.0000000000000485
Pattinson CL, Gill JM, Lippa SM, Brickell TA, French LM, Lange RT. Concurrent mild traumatic brain injury and posttraumatic stress disorder is associated with elevated tau concentrations in peripheral blood plasma. J Trauma Stress. 2019;32(4):546–554. doi:10.1002/jts.22418
Lippa SM, Gill J, Brickell TA, French LM, Lange RT. Blood biomarkers relate to cognitive performance years after traumatic brain injury in service members and veterans. J Int Neuropsychol Soc. 2021;27(5):508–514. doi:10.1017/S1355617720001071
Guedes VA, Kenney K, Shahim P, et al. Exosomal neurofilament light: A prognostic biomarker for remote symptoms after mild traumatic brain injury? Neurology. 2020;94(23):e2412–e2423. doi:10.1212/WNL.0000000000009577
Kenney K, Qu BX, Lai C, et al. Higher exosomal phosphorylated tau and total tau among veterans with combat-related repetitive chronic mild traumatic brain injury. Brain Inj. 2018;32(10):1276–1284. doi:10.1080/02699052.2018.1483530
Gottshall JL, Agyemang AA, O'Neil M, et al. Sleep quality: a common thread linking depression, post-traumatic stress, and post-concussive symptoms to biomarkers of neurodegeneration following traumatic brain injury. Brain Inj. 2022;36(5):633–643. doi:10.1080/02699052.2022.2037711
Gottshall JL, Guedes VA, Pucci JU, et al. Poor sleep quality is linked to elevated extracellular vesicle-associated inflammatory cytokines in warfighters with chronic mild traumatic brain injuries. Front Pharmacol. 2021;12:762077. doi:10.3389/fphar.2021.762077
Motamedi V, Kanefsky R, Matsangas P, et al. Elevated tau and interleukin-6 concentrations in adults with obstructive sleep apnea. Sleep Med. 2018;43:71–76. doi:10.1016/j.sleep.2017.11.1121
Gaetani L, Blennow K, Calabresi P, Di Filippo M, Parnetti L, Zetterberg H. Neurofilament light chain as a biomarker in neurological disorders. J Neurol Neurosurg Psychiatry. 2019;90(8):870–881. doi:10.1136/jnnp-2018-320106
Palmqvist S, Janelidze S, Quiroz YT, et al. Discriminative Accuracy of plasma phospho-tau217 for Alzheimer disease vs other neurodegenerative disorders. JAMA. 2020;324(8):772–781. doi:10.1001/jama.2020.12134
Hossain I, Mohammadian M, Takala RSK, et al. Early levels of glial fibrillary acidic protein and neurofilament light protein in predicting the outcome of mild traumatic brain injury. J Neurotrauma. 2019;36(10):1551–1560. doi:10.1089/neu.2018.5952
Thelin E, Al Nimer F, Frostell A, et al. A serum protein biomarker panel improves outcome prediction in human traumatic brain injury. J Neurotrauma. 2019;36(20):2850–2862. doi:10.1089/neu.2019.6375
Shahim P, Gren M, Liman V, et al. Serum neurofilament light protein predicts clinical outcome in traumatic brain injury. Sci Rep. 2016;6:36791. doi:10.1038/srep36791
Shahim P, Tegner Y, Marklund N, Blennow K, Zetterberg H. Neurofilament light and tau as blood biomarkers for sports-related concussion. Neurology. 2018;90(20):e1780–e1788. doi:10.1212/WNL.0000000000005518
Pattinson CL, Meier TB, Guedes VA, et al. Plasma biomarker concentrations associated with return to sport following sport-related concussion in collegiate athletes—a Concussion Assessment, Research, and Education (CARE) Consortium Study. JAMA Netw Open. 2020;3(8):e2013191. doi:10.1001/jamanetworkopen.2020.13191
Lange RT, Lippa SM, Brickell TA, Gill JM, French LM. Serum tau, neurofilament light chain, glial fibrillary acidic protein, and ubiquitin carboxyl-terminal hydrolase L1 are associated with the chronic deterioration of neurobehavioral symptoms after traumatic brain injury. J Neurotrauma. 2023;40(5-6):482–492. doi:10.1089/neu.2022.0249
Corrigan JD, Bogner J. Initial reliability and validity of the Ohio State University TBI Identification Method. J Head Trauma Rehabil. 2007;22(6):318–329. doi:10.1097/01.HTR.0000300227.67748.77
Lange RT, French LM, Lippa SM, Bailie JM, Brickell TA. Posttraumatic stress disorder is a stronger predictor of long-term neurobehavioral outcomes than traumatic brain injury severity. J Trauma Stress. 2020;33(3):318–329. doi:10.1002/jts.22480
Lange RT, Lippa SM, French LM, et al. Long-term neurobehavioural symptom reporting following mild, moderate, severe, and penetrating traumatic brain injury in U.S. military service members. Neuropsychol Rehabil. 2020;30(9):1762–1785. doi:10.1080/09602011.2019.1604385
Lippa SM, French LM, Bell RS, Brickell TA, Lange RT. United States military service members demonstrate substantial and heterogeneous long-term neuropsychological dysfunction after moderate, severe, and penetrating traumatic brain injury. J Neurotrauma. 2020;37(4):608–617. doi:10.1089/neu.2019.6696
Lippa SM, Yeh PH, Gill J, French LM, Brickell TA, Lange RT. Plasma tau and amyloid are not reliably related to injury characteristics, neuropsychological performance, or white matter integrity in service members with a history of traumatic brain injury. J Neurotrauma. 2019;36(14):2190–2199. doi:10.1089/neu.2018.6269
Tulsky DS, Kisala PA, Victorson D, et al. TBI-QOL: development and calibration of item banks to measure patient reported outcomes following traumatic brain injury. J Head Trauma Rehabil. 2016;31(1):40–51. doi:10.1097/HTR.0000000000000131
Cicerone K, Kalmar K. Persistent postconcussion syndrome: the structure of subjective complaints after mild traumatic brain injury. J Head Trauma Rehabil. 1995;10(3):1–7.
Vanderploeg RD, Cooper DB, Belanger HG, et al. Screening for postdeployment conditions: development and cross-validation of an embedded validity scale in the Neurobehavioral Symptom Inventory. J Head Trauma Rehabil. 2014;29(1):1–10. doi:10.1097/HTR.0b013e318281966e
Armistead-Jehle P, Cooper DB, Grills CE, et al. Clinical utility of the mBIAS and NSI Validity-10 to detect symptom over-reporting following mild TBI: a multicenter investigation with military service members. J Clin Exp Neuropsychol. 2018;40(3):213–223. doi:10.1080/13803395.2017.1329406
Dretsch MN, Williams K, Staver T, et al. Evaluating the clinical utility of the Validity-10 for detecting amplified symptom reporting for patients with mild traumatic brain injury and comorbid psychological health conditions. Appl Neuropsychol Adult. 2017;24(4):376–380. doi:10.1080/23279095.2016.1220947
Sullivan KA, Lange RT, Edmed SL. Utility of the Neurobehavioral Symptom Inventory Validity-10 index to detect symptom exaggeration: an analogue simulation study. Appl Neuropsychol Adult. 2016;23(5):353–362. doi:10.1080/23279095.2015.1079714
Lippa SM, Lange RT, Bailie JM, Kennedy JE, Brickell TA, French LM. Utility of the Validity-10 scale across the recovery trajectory following traumatic brain injury. J Rehabil Res Dev. 2016;53(3):379–390. doi:10.1682/JRRD.2015.01.0009
Lange RT, Brickell TA, Lippa SM, French LM. Clinical utility of the Neurobehavioral Symptom Inventory validity scales to screen for symptom exaggeration following traumatic brain injury. J Clin Exp Neuropsychol. 2015;37(8):853–862. doi:10.1080/13803395.2015.1064864
Lange RT, Brickell TA, French LM. Examination of the Mild Brain Injury Atypical Symptom Scale and the Validity-10 Scale to detect symptom exaggeration in US military service members. J Clin Exp Neuropsychol. 2015;37(3):325–337. doi:10.1080/13803395.2015.1013021
Bogoslovsky T, Gill J, Jeromin A, Davis C, Diaz-Arrastia R. Fluid biomarkers of traumatic brain injury and intended context of use. Diagnostics (Basel). 2016;6(4):37. doi:10.3390/diagnostics6040037
Shahim P, Politis A, van der Merwe A, et al. Time course and diagnostic utility of NfL, tau, GFAP, and UCH-L1 in subacute and chronic TBI. Neurology. 2020;95(6):e623–e636. doi:10.1212/WNL.0000000000009985
Castellani RJ, Perry G. Tau biology, tauopathy, traumatic brain injury, and diagnostic challenges. J Alzheimers Dis. 2019;67(2):447–467. doi:10.3233/JAD-180721
Gong B, Leznik E. The role of ubiquitin C-terminal hydrolase L1 in neurodegenerative disorders. Drug News Perspect. 2007;20(6):365–370. doi:10.1358/dnp.2007.20.6.1138160
Giza CC, McCrea M, Huber D, et al. Assessment of blood biomarker profile after acute concussion during combative training among us military cadets: a prospective study from the NCAA and US Department of Defense CARE Consortium. JAMA Netw Open. 2021;4(2):e2037731. doi:10.1001/jamanetworkopen.2020.37731